# Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)

> **NCT00070655** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 4673 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** SR34006 (idraparinux sodium) Injection
- **DRUG:** vitamin K antagonist (warfarin or acenocoumarol) tablets

## Key facts

- **NCT ID:** NCT00070655
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 4673 (ACTUAL)
- **Last updated:** 2011-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00070655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00070655, "Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00070655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*